Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay
Invivoscribe is a global, vertically-integrated biotechnology company dedicated to Improving Lives with Precision Diagnostics
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
24 Jul 23
Invivoscribe is a global, vertically-integrated biotechnology company dedicated to Improving Lives with Precision Diagnostics
21 Jul 23
XR90 is an augmented reality (AR) based diverse imaging platform used to visualise patient anatomy and instrumentation pathway,…
21 Jul 23
The OLO study is designed to evaluate the effectiveness of the Magnus neuromodulation system with SAINT technology for…
21 Jul 23
The diagnostic products maker has designed the Candida auris test to identify C. auris species from blood in…
21 Jul 23
The latest addition to Siemens Healthineers Atellica in vitro diagnostics portfolio is said to offer enhanced turnaround time…
21 Jul 23
Rapid Medical pioneers advanced interventional devices to treat neurovascular diseases such as ischemic and hemorrhagic stroke.
21 Jul 23
With this collaboration Neoss Group and Osstell AB solidify their positions as key players in the dental industry
20 Jul 23
Inspira will combine its INSPIRA ART100 offering, an extracorporeal blood circulation device that directly oxygenates the blood and…
20 Jul 23
The LiLii platform uses proprietary LiVeritas AI to simplify workflows, bring down inefficiencies, and streamline productivity for drug…
20 Jul 23
Intel Capital managing director Srini Ananth will also join SiPhox Health’s board of directors to further accelerate the…